Lantheus Holdings

LNTH · NASDAQ

$100.39+$0.47 (+0.47%)TodayMarket closed ·
Prev close $99.92

About LNTH

The company is headquartered in North Billerica, Massachusetts and currently employs 1,193 full-time employees. The company went IPO on 2015-06-25.

Employees
1,193
Headquarters
North Billerica, Massachusetts
Listed
Jun 25, 2015
Sector
Health Care
Industry
Health Care Equipment & Supplies

LNTH key statistics

Market cap
6.52B
Price-earnings ratio
24.19
Dividend yield
—
Average volume
1.05M
Volume
1.33M
Open price
$100.07
High today
$100.40
Low today
$99.81
52 Week high
$111.86
52 Week low
$50.16

Lantheus Holdings (LNTH) at a glance

As of Oct 20, 2026, Lantheus Holdings (LNTH) shares are priced at $100.39, giving the company a market cap of 6.52B and a price-to-earnings ratio of 24.19.

Today the stock has traded between $99.81 and $100.40. The current price is 0.6% above the day's low and 0.0% below its high.

Volume so far is 1.33M shares, above the average of 1.05M shares a day.

Over the past year Lantheus Holdings has ranged from $50.16 to $111.86, and now sits 81% of the way up that range.

Lantheus Holdings met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $1.55 per share against an estimate of $1.33.

The average analyst price target is $105.62, 5.2% above the current price, from 7 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

29%of 7 analyst ratings say Buy
  • Buy28.6%
  • Hold71.4%
  • Sell0.0%
Price target · 11 analystsAvg $105.62
Low
$70.70
Now
$100.39
High
$120.75

LNTH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 16.3% on average.

  1. Q3 FY24: reported $1.70 per share against an estimate of $1.59
  2. Q4 FY24: reported $1.59 per share against an estimate of $1.56
  3. Q1 FY25: reported $1.53 per share against an estimate of $1.69
  4. Q2 FY25: reported $1.57 per share against an estimate of $1.71
  5. Q3 FY25: reported $1.27 per share against an estimate of $1.29
  6. Q4 FY25: reported $1.67 per share against an estimate of $1.19
  7. Q1 FY26: reported $1.46 per share against an estimate of $1.26
  8. Q2 FY26: reported $1.55 per share against an estimate of $1.33

LNTH news

  • Press releasePRNewswire

    Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?

  • Press releasePRNewswire

    ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH

  • Press releasePRNewswire

    Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?

  • Press releaseBusiness Wire

    Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH

  • Press releaseBusiness Wire

    LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders

  • Vandana Singh

    FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics

  • Press releasePRNewswire

    Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?

  • Press releaseBusiness Wire

    Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH

Similar companies

Companies in the same industry as Lantheus Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.